Mind Medicine (MindMed) Inc MNMD
$15.02 $0.15 (1.01%) 1D
Last Updated: Jan 14, 12:00 AM·NASDAQ
Pricing for US stocks is delayed by 24 hours
MNMD Shariah Compliance
Screening Methodology: AAOIFI
As of August 2026, Mind Medicine (MindMed) Inc is classified as not halal.
NOT HALAL
Report Source: undefined Quarter Report
Mind Medicine (MindMed) Inc. Stock Analysis MNMD
United States Health Care Small Cap Mind Medicine (MindMed), Inc. operates as clinical stage biopharmaceutical company, which engages in developing novel product candidates to treat brain health disorders. The company is headquartered in New York City, New York and currently employs 74 full-time employees. The company went IPO on 2015-05-04. The firm is developing a pipeline of product candidates, with and without acute perceptual effects, targeting neurotransmitter pathways that play key roles in brain health. This specifically includes pharmaceutically optimized product candidates derived from the psychedelic and empathogen drug classes, including MM120 and MM402, its lead product candidates. Its lead product candidate, MM120, is a proprietary, pharmaceutically optimized form of lysergide D-tartrate that the Company is developing for the treatment of generalized anxiety disorder and major depressive disorder. Its second lead product candidate, MM402, also referred to as R(-)-MDMA, is its proprietary form of the R-enantiomer of 3,4-methylenedioxymethamphetamine (MDMA), which the Company is developing for the treatment of autism spectrum disorder (ASD).
Mind Medicine (MindMed) Inc (MNMD) Chart
Financial Metrics & Statements of Mind Medicine (MindMed) Inc (MNMD)
FAQ's for Mind Medicine (MindMed) Inc (MNMD)
- As of August 2026, Mind Medicine (MindMed) Inc MNMD is classified as not halal according to Musaffa’s Shariah screening methodology. This classification is based on an assessment of the company’s business activities and financial ratios against Islamic investment guidelines.
- A stock is Shariah-compliant if the company operates in permissible business activities and meets Islamic financial screening thresholds. Musaffa analyzes Mind Medicine (MindMed) Inc using these criteria to determine its compliance status.
- Muslim investors may consider investing in Mind Medicine (MindMed) Inc if it meets Shariah compliance standards. Investors typically review the company’s business activities, debt levels, and non-permissible income before making a decision.
- Musaffa determines the Shariah status of Mind Medicine (MindMed) Inc by analyzing whether the company’s core business operations are permissible and whether its financial ratios fall within accepted Islamic thresholds.
- The Shariah compliance status of Mind Medicine (MindMed) Inc may be updated periodically when new financial statements, earnings reports, or business activity information become available.
- Yes. A stock that is currently Shariah-compliant may become non-compliant if the company’s financial ratios exceed Shariah thresholds or its business activities change.
- You can check the latest Shariah compliance status of Mind Medicine (MindMed) Inc on Musaffa’s stock page, where screening results and key financial indicators are updated to help Muslim investors make informed decisions.
Alternate Halal Stocks for Mind Medicine (MindMed) Inc (MNMD)
Related Halal Stocks are Shariah-compliant companies that align with Islamic investment principles, avoiding prohibited industries like alcohol, gambling, and interest-based finance.
